Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

REALMUTO, Sabrina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.560
EU - Europa 4.694
AS - Asia 3.301
SA - Sud America 469
AF - Africa 119
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 12
Totale 15.177
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.425
IT - Italia 1.427
RU - Federazione Russa 1.117
SG - Singapore 1.069
CN - Cina 853
FI - Finlandia 566
BR - Brasile 372
VN - Vietnam 352
HK - Hong Kong 291
DE - Germania 248
IE - Irlanda 230
PL - Polonia 220
FR - Francia 173
GB - Regno Unito 171
UA - Ucraina 152
KR - Corea 144
JP - Giappone 119
IN - India 90
BD - Bangladesh 89
BE - Belgio 83
NL - Olanda 82
IR - Iran 56
CA - Canada 55
SE - Svezia 45
IQ - Iraq 40
RO - Romania 39
TR - Turchia 39
MX - Messico 36
AR - Argentina 34
EG - Egitto 33
ES - Italia 33
AT - Austria 24
CI - Costa d'Avorio 24
ID - Indonesia 22
AU - Australia 20
UZ - Uzbekistan 18
PK - Pakistan 17
CZ - Repubblica Ceca 15
MA - Marocco 15
VE - Venezuela 15
GR - Grecia 13
KE - Kenya 13
EC - Ecuador 12
NP - Nepal 12
LT - Lituania 11
MY - Malesia 11
EU - Europa 10
HN - Honduras 10
JM - Giamaica 10
ZA - Sudafrica 10
CL - Cile 9
CO - Colombia 9
IL - Israele 9
JO - Giordania 9
SA - Arabia Saudita 9
TW - Taiwan 8
DZ - Algeria 7
PY - Paraguay 7
TN - Tunisia 7
AE - Emirati Arabi Uniti 6
AL - Albania 6
CH - Svizzera 6
DK - Danimarca 6
PH - Filippine 6
TH - Thailandia 6
KZ - Kazakistan 5
MD - Moldavia 5
CR - Costa Rica 4
GE - Georgia 4
LB - Libano 4
SK - Slovacchia (Repubblica Slovacca) 4
UY - Uruguay 4
AZ - Azerbaigian 3
BO - Bolivia 3
ET - Etiopia 3
HU - Ungheria 3
NO - Norvegia 3
OM - Oman 3
PA - Panama 3
PT - Portogallo 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
GT - Guatemala 2
KG - Kirghizistan 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PE - Perù 2
PR - Porto Rico 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BF - Burkina Faso 1
BG - Bulgaria 1
BS - Bahamas 1
CY - Cipro 1
DM - Dominica 1
Totale 15.162
Salva come PNG Salva come JPEG
Città #
Ashburn 894
Singapore 680
Fairfield 517
Chandler 436
San Jose 406
Woodbridge 307
Ann Arbor 292
Hong Kong 279
Wilmington 256
Houston 245
Seattle 234
Moscow 229
Dublin 228
Cambridge 176
Zgierz 172
Palermo 158
Medford 142
Beijing 125
Ho Chi Minh City 121
Des Moines 111
Nanjing 108
Los Angeles 107
Tokyo 106
New York 104
Milan 103
Dallas 100
Princeton 88
Boardman 87
Jacksonville 81
Santa Clara 76
Hanoi 75
Council Bluffs 72
Lauterbourg 72
Brussels 71
The Dalles 66
Frankfurt am Main 56
Rome 55
Seoul 55
Altamura 52
Shenyang 43
Tulsa 41
Lawrence 40
Changsha 39
Dearborn 39
Buffalo 38
Helsinki 38
San Diego 37
Venice 33
Jinan 32
Orem 32
Nanchang 29
Hebei 28
São Paulo 28
Phoenix 26
Jiaxing 25
Abidjan 24
Florence 24
London 24
Tianjin 24
Nuremberg 23
Verona 23
Tehran 22
Zhengzhou 22
Amsterdam 21
Naples 20
Da Nang 19
Warsaw 19
Chicago 18
Baghdad 17
Brooklyn 17
Saint Petersburg 17
Toronto 17
Atlanta 16
Chennai 16
Guangzhou 16
Hangzhou 16
Seongnam 16
Turin 16
Giza 15
Munich 15
Washington 15
Belo Horizonte 14
Brno 14
Haiphong 14
Ningbo 14
Falls Church 13
Hefei 13
Kumar 13
Ludwigshafen am Rhein 13
Montreal 13
New Delhi 13
Catania 12
Haikou 12
Istanbul 12
Norwalk 12
Redwood City 12
Tashkent 12
Ankara 11
Kraków 11
Poplar 11
Totale 8.821
Salva come PNG Salva come JPEG
Nome #
Emotion recognition from facial expressions: a normative study of the Ekman 60-Faces Test in the Italian population. 621
Four cases of progressive multifocal leukoencephalopathy in iatrogenic immunocompromised patients 367
Quantitative EEG differentiate Multiple Sclerosis with and without Cognitive Impairment from healthy controls at the beginning of the disease: preliminary data 355
Association between multiple sclerosis, cancer risk, and immunosuppressant treatment: A cohort study 289
Anodal transcranial direct current stimulation over the right hemisphere improves auditory comprehension in a case of dementia 277
Cardiovascular comorbidity in multiple sclerosis patients treated with mitoxantrone therapy: a cohort study 270
VDBP, CYP27B1, and 25-Hydroxyvitamin D Gene Polymorphism Analyses in a Group of Sicilian Multiple Sclerosis Patients 267
Effect of extracellular vesicles from CSF of multiple sclerosis patients and healthy controls on astrocytes in culture 264
Sleep quality in caregivers of patients with Alzheimer’s disease and Parkinson’s disease and its relationship to quality of life 262
A population-based survey of cognitive performance in a Sicilian elderly community. 260
Klotho and vitamin D in multiple sclerosis: an Italian study 257
EARLY AND LATE MORTALITY OF SPONTANEOUS HEMORRHAGIC TRANSFORMATION OF ISCHEMIC STROKE 256
Application of tRNS to improve multiple sclerosis fatigue: a pilot, single-blind, sham-controlled study 254
Clinical features, disease course and prognosis in patients with paediatric and young adult onset multiple sclerosis 249
Differences in intercellular communication during clinical relapse and gadolinium-enhanced MRI in patients with relapsing remitting multiple sclerosis: A study of the composition of extracellular vesicles in cerebrospinal fluid 247
Insidious onset of Pisa syndrome after rasagiline therapy in a patient with Parkinson’s disease 238
Anodal tDCS of the swallowing motor cortex for treatment of dysphagia in multiple sclerosis: a pilot open-label study 235
The Ekman 60-faces test: an italiana normative study 233
Quantitative EEG differentiates multiple sclerosis with and without cognitive impairment from healthy controls at the beginning of the disease: preliminary data 226
DYSAUTONOMIC DYSFUNCTION IN PARKINSON’DISEASE BY SCOPA-AUT SCALE 214
Application of tRNS to improve Multiple Sclerosis Fatigue: a sham-controlled study 209
Extracellular vesicles isolated by cerebrospinal fluid as biomarkers of inflammation in multiple sclerosis and inflammatory neurological diseases. 204
Neurofunctional correlates of attention rehabilitation in Parkinson's disease: an explorative study 201
REM sleep behavior disorder in a patient with frontotemporal dementia 197
Treatment of Relapsing-Remitting Multiple Sclerosis After 24 Doses of Natalizumab: Evidence From an Italian Spontaneous, Prospective, and Observational Study (the TY-STOP Study). 196
Social cognition dysfunctions in patients with epilepsy: Evidence from patients with temporal lobe and idiopathic generalized epilepsies. 195
Lesion Load May Predict Long-Term Cognitive Dysfunction in Multiple Sclerosis Patients 193
Natalizumab Discontinuation and Treatment Strategies in Patients with Multiple Sclerosis (MS): A Retrospective Study from Two Italian MS Centers 189
Thalamic stroke mimicking frontotemporal dementia: a case report 188
Frontal dementia related to thalamic stroke: a case report. 181
Frequency and clinical features of progranulin mutation carriers in a series of patients affected by frontotemporal lobar de generation: report of a novel mutation 178
Clinical features and disease out come in patients with pediatric and young adult onset Multiple Sclerosis 178
IMMUNOSUPPRESSANT TREATMENT AND CANCER RISK IN A COHORT OF PATIENTS AFFECTED BY MULTIPLE SCLEROSIS 176
DYSAUTOMIC DISFUNCTON OCCURS EARLY IN PARKINSON DISEASE 176
Tumor diagnosis preceding Alzheimer's disease onset: is there a link between cancer and Alzheimer's disease? 175
NEURODEGENERATION IN MULTIPLE SCLEROSIS: COMPARISON BETWEEN CLINICAL, NEUROPSYCHOLOGICAL, MRI,AND OPTICAL COHERENCE TOMOGRAPHY PARAMETERS 175
PARKINSON’S DISEASE AND PARKINSON’S DISEASE FAMILIAL HISTORY. RESULTS OF A CASE-CONTROL STUDY 174
Frequency of cognitive impairment and factors associated in outpatients with Parkinson’s disease 170
Frequency of John Cunningham virus (JCV) DNA and of antibodies against JCV in patients affected by multiple sclerosis and their relationship with natalizumab therapy 168
ELECTROCARDIOGRAPHIC FINDINGS IN PATIENTS WITH DEMENTIA. 165
Rey-Osterrieth Complex figure performance in patients with degenerative dementia using Boston Qualitative Scoring System 161
Reversible Pisa Syndrome in a patient with Parkinson's Disease on rasagiline therapy 158
Clinical and instrumental predictors of efficacy of natalizumab therapy in the course of multiple sclerosis: a retrospective study from a single centre 158
Purine metabolism and Multiple Sclerosis: different pattern according to different disease stage and different clinical form. 156
Quetiapine dose-sparing effect with addiction of memantine: two cases report of Lewy Body disease and dementia associated with Parkinson’s disease 153
Clinical and Instrumental Findings and Disability Progression in Primary Progressive and Progressive Relapsing Multiple Sclerosis: A Comparison Study of a Sicilian Group of Patients 152
Clinical and instrumental predictors of efficacy of Natalizumab therapy in multiple sclerosis patients: a retrospective study from a single centre 152
PRIMARY PROGRESSIVE CROSSED APHASIA IN A DEXTRAL WOMAN 151
Chronic acquired hepatocerebral degeneration or Parkinson Disease? A case report 151
Real world experience with teriflunomide in multiple sclerosis: the TER-Italy study 151
Frequency of Mitoxantrone related heart involvement in patients affected by Multiple Sclerosis 150
Modulation of action tremor by repetitive transcranial magnetic stimulation in multiple sclerosis patients 149
Pisa syndrome after rasagiline therapy in a patient with Parkinson’s disease 148
PREGNANCIES MODIFY RELAPSES AND PROGRESSION IN MULTIPLE SCLEROSIS 146
Approccio multidimensionale ai disturbi non motori della Malattia di Parkinson 142
COGNITIVE IMPAIRMENT IN PATIENTS WITH PARKINSON’S DISEASE 141
In patient’s with Parkinson disease, autonomic symptoms are frequent and associated with other non-motor symptoms 141
Back to the life: a case of tretable dementia 136
Heart involvement in patients treated with mitoxantrone for multiple sclerosis 136
RISK FACTORS FOR DYSKINESIAS IN PATIENTS WITH PARKINSON'S DISEASE 135
Emotion recognition in temporal lobe epilepsy and idiopathic generalized epilepsy 135
Sleep and sleepiness in Parkinson’s disease: result of a “spontaneous” observational study on rotigotine 135
Sleep disturbances and dysautonomic dysfunction are associated in patients with Parkinson’s disease 133
EXTRACELLULAR VESICLES IN CEREBROSPINAL FLUID AS MARKERS OF CNS INFLAMMATION 130
Return of disease activity after natalizumab therapy discontinuation in patients with multiple sclerosis: frequency and clinical and instrumental predictors of reactivation 126
Clinical Features and disease outcome in pt with pediatric and young adult onset multiple sclerosis 126
Sleep quality in caregivers of Parkinson’s disease and Alzheimer’s disease patients and its relationship to quality of life 125
INFLUENCE OF REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION (RTMS) ON ACTION TREMOR IN MULTIPLE SCLEROSIS PATIENTS 121
Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register 117
Primary Progressive and progressive relapsing multiple sclerosis show different clinical and instrumental findings and disability progression? A comparison study on a Sicilian database 117
EMpathy ability and emotion recognition in temporal lobe epilepsy and idhiopathic generalizede epileps 116
Natalizumab therapy of relapsing-remitting multiple sclerosis: an evaluation of the safety profile and a comparison of efficacy with interferon beta therapy 110
Urinary dysfunction in Parkinson’s disease patients 110
Toxic effects on astrocytes of extracellular vesicles from CSF of multiple sclerosis patients: A pilot in vitro study 110
Computer-assisted cognitive remediation for Parkinson’s disease 108
Tumor diagnosis preceding Alzheimer’s disease: a case-control study 104
Identification of three novel progranulin mutations in a series of patients affected by sporadic and familial frontotemporal lobar de generation. Platform Presentation 103
Psychosis as adverse effect of cholinesterase inhibitors: two case reports of probable Alzheimer disease in treatment with galantamine 100
Natalizumab Discontinuation after the 24th Course: Which Is Way? The TY-STOP Study 99
Primary progressive crossed aphasia in dextrals: report of three cases 98
Mitochondrial DNA TRNACYS mutation in a family with frontotemporal dementia and Parkinson’s disease 94
Discontinuation of treatment with Natalizumab after 24 courses. Report from spontaneous, observational, prospective study (TYSTOP). 92
Multiple reversibile MR signals in course of Epstein-Barr virus encephalitis 91
Lifestyle factors and multiple sclerosis: a case control study 85
Looking for the best therapeutical stretegy after the 24th natalizumab adiministretion. The TY-STOP study 83
Purine metabolism and multiple sclerosis: pattern varies according to disease stage and clinical form 80
Reduced striatal dopamine transporter binding in posterior cortical atrophy 79
Treatment of multiple sclerosis patients after 24 Natalizumab doses: a prospective observational study: the TY-STOP 73
TREATMENT CHOICE AFTER 24 NATALIZUMAB DOSES IN PATIENTS WITH MULTIPLE SCLEROSIS: A PROSPECTIVE OBSERVATIONAL STUDY, THE TY-STOP 65
LATE MORTALITY OF HEMORRHAGIC TRANSFORMATION OF ISCHEMIC STROKE 55
null 44
null 37
null 3
Totale 15.500
Salva come PNG Salva come JPEG
Categoria #
all - tutte 50.636
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.636
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022963 49 205 40 47 31 43 31 64 105 110 45 193
2022/20231.577 149 184 51 151 272 253 95 125 177 18 84 18
2023/2024817 35 122 37 82 75 143 44 63 17 46 27 126
2024/20251.656 63 96 92 172 109 51 92 96 128 164 244 349
2025/20265.654 489 141 299 387 561 904 724 662 492 519 244 232
2026/2027130 130 0 0 0 0 0 0 0 0 0 0 0
Totale 15.500